Skip to main content
Log in

Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We determined plasma methocarbamol concentrations over 24 h following a 1.5 g methocarbamol dose (off-dialysis day) to 8 chronic haemodialysis patients and compared these results to those from 17 healthy male volunteers.

The harmonic mean elimination half-life was similar between the two groups, 1.24 and 1.14 h, respectively. tmax and the weight-adjusted Cmax were 1.1 h and 27.0 mg · m−1 for haemodialysis patients and 1.1 and 23.1 mg · l−1 for normals. Relative systemic availability was assessed by comparing weight-normalized AUC × k10 products.

These results indicate no significant differences with respect to methocarbamol absorption, with the relative systemic availability in patients being 113%.

These data suggest that absorption and elimination of methocarbamol is similar between normal subjects and patients undergoing maintenance haemodialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bruce RB, Turnbull LB, Newman JH (1971) Metabolism of methocarbamol in the rat, dog, and human. J Pharm Sci 60: 104–106

    Google Scholar 

  2. Gibson TP (1986) Renal disease and drug metabolism: An overview. Am J Kidney Dis 8: 7–17

    Google Scholar 

  3. Quintanilla AP (1986) Liver dysfunction in dialysis patients. Int J Artif Intern Organs 9: 1–2

    Google Scholar 

  4. Simon P, Meyrier A, Brissot P (1981) Uremia and the liver. II. Drugs and the liver in the uremic patient. Nephron 29: 7–13

    Google Scholar 

  5. Verbeeck RK (1982) Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review. Drug Metab Disp 10: 87–89

    Google Scholar 

  6. Wagner JG (1967) Method of estimating relative absorption of a drug in a series of clinical studies in which blood levels are measured after single and/or multiple doses. J Pharm Sci 56: 652–653

    Google Scholar 

  7. Wagner JG (1978) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, pp 347–348

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sica, D.A., Comstock, T.J., Davis, J. et al. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. Eur J Clin Pharmacol 39, 193–194 (1990). https://doi.org/10.1007/BF00280060

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280060

Key words

Navigation